Abstract
Tumors can evade conventional T cell recognition by rendering the HLA class I antigen presentation system defective. In a recent study, de Vries et al. reveal γδ T cells as key contributors to the efficacy of immune checkpoint blockade (ICB) against HLA-I-silenced cancers, highlighting a novel layer of surveillance against immune escape by tumors.
Original language | English (US) |
---|---|
Pages (from-to) | 159-161 |
Number of pages | 3 |
Journal | Trends in Immunology |
Volume | 44 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2023 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology